Daniel Alfonso Flores Cordero
FDA import alert and refusal historyCol. Centro, MexicoFEI 3011710918
As of October 26, 2026, Daniel Alfonso Flores Cordero (Col. Centro, Mexico) is on the red list of FDA Import Alert 99-05 (Raw agricultural products: pesticides) for fresh jalapeno peppers, published by FDA on November 12, 2013, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-05 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Daniel Alfonso Flores Cordero
1 record, newest first. Each line links to the FDA page it came from.
2013
- Import alert listingListed on Import Alert 99-05red listFresh Jalapeno PeppersSource
Questions about Daniel Alfonso Flores Cordero
- Is Daniel Alfonso Flores Cordero on an FDA import alert?
- Yes. As of October 26, 2026, Daniel Alfonso Flores Cordero is on the red list of FDA Import Alert 99-05, “Raw agricultural products: pesticides”, for fresh jalapeno peppers; FDA published the listing on November 12, 2013.
- Has FDA refused shipments from Daniel Alfonso Flores Cordero?
- No FDA import refusals for Daniel Alfonso Flores Cordero appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Daniel Alfonso Flores Cordero's FEI number?
- Daniel Alfonso Flores Cordero's FDA Establishment Identifier (FEI) is 3011710918.
- Can shipments from Daniel Alfonso Flores Cordero still enter the U.S.?
- Shipments of fresh jalapeno peppers from Daniel Alfonso Flores Cordero can be detained without physical examination under Import Alert 99-05; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Daniel Alfonso Flores Cordero?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.